Connect with us

Technology

3D Artificial Cornea from Stem Cells: Chula Researchers Advance Canine Corneal Wound Treatment

Published

on

BANGKOK, July 10, 2024 /PRNewswire/ — Chulalongkorn University’s Faculty of Veterinary Science and the Faculty of Engineering have worked together to research and develop a three-dimensional artificial cornea from stem cells that offers a way to treat deep corneal wounds in dogs. The innovation helps to solve the problem of treatment methods that rely on tissue replacement which is hard to find and very expensive.  It makes it possible for dogs to be able to see clearly and comfortably once again.  

Does your dog have any of these symptoms? The inability to fully open its eyes, squinting or blinking frequently, shedding lots of tears, sometimes the tears are thick, and the mucus appears greenish.  The sclera is unusually red and not clear like before.  The cornea becomes cloudy and there are blood vessels in it.   

If your answer is “yes” then your pet might be suffering from a corneal ulcer which, if left untreated could eventually cause blindness.   

Nowadays, the number of dogs receiving treatment for corneal ulcers has increased tremendously.  The small animal hospital at the Faculty of Veterinary Medicine, Chulalongkorn University alone is already treating dogs with corneal ulcers daily.   

“We find quite a number of lesions like this in dogs.  Corneal ulcers occur as a result of many reasons, such as dogs scratching their own eyes because they have allergies causing itching around the eyes followed by scratching until the lesions form.  Fights with other dogs, being scratched by a cat, or accidentally bumps into objects” Veterinarian Dr. Chutirat Torssahakul of the Department of Internal Medicine, Faculty of Veterinary Medicine, Chulalongkorn University addressed the problems that became the starting point for the research and innovation development.  “Three-dimensional artificial cornea from stem cells” enables your beloved pet to have perfect vision once again.  “The current treatment being used is to have grafts made from replacement tissue derived from porcine bladder or canine placentas which are rare and relatively expensive.  There is also the possibility of causing post-surgery reaction and inflammation.  Therefore, we thought that if we could produce our own innovative artificial cornea using natural materials that are easily found and reduce the chance of causing inflammation this might be a better option.”  Dr. Chutirat explained.    

Three-dimensional artificial cornea from stem cells – a brighter alternative 

As a result of the effort and intention to solve eye problems for dogs, the Faculty of Veterinary Science’s research team through the Veterinary Stem Cell and Bioengineering Innovation Center (VSCBIC) has therefore embarked on additional studies on stem cells and is working with the Biomedical Engineering Research Center of the Faculty of Engineering, Chulalongkorn University recognizing its expertise in tissue engineering to help make adhesive materials for growing stem cells. 

According to Veterinary Professor Dr. Chutirat “Artificial corneal tissue is obtained by cultivating real dog corneal stem cells on a natural material structure made from silk fibroin mixed with gelatin.  The material can be cheaply and easily found in Thailand.  It is strong and durable, clear and transparent, and adheres well to cells making them three-dimensional which is comparable to real corneal tissue.” 

This innovation can be used to treat corneal perforations in dogs as well as large corneal wounds where the tissue cannot be stitched or even deep wounds in which a large amount of corneal tissue has been lost.  In cases of dogs with mild or moderate levels of corneal ulcer problems, currently, 2 methods for treatment are still in use.   

Treatment with topical eye drops is usually used in cases that are not too severe, such as a superficial wound or a bit deeper layer. Treatment with eye drops can help prevent complications due to secondary infections.  The drops do not help, however, with healing wounds since that depends on the dog’s own body mechanisms. If the body is strong and there is normal cell growth, then most cases will recover on their own.  

Treatment with surgery is used in cases of very deep wounds, complicated wounds, reaching the last layer of the cornea, or penetrating wounds where it is still possible to stitch the corneas together normally. 

“But in cases where the wound in the cornea is so large that tissue must be used to replace the missing part, we usually use a graft which could be the dog’s own conjunctiva.  The other option is to use replacement tissue such as tissues derived from human or canine placentas.  These are costly and difficult to find so we have invented a new way to treat them and that is the three-dimensional artificial cornea made from stem cells.” 

4 outstanding features of the 3D artificial cornea innovation  

It appears very similar to the real corneal surface – Research shows that stem cells grown in the lab can create tissue cells.  The extracellular matrix is interconnected and the outline is similar to the real corneal surface.  In particular, the arrangement of stem cells in the cornea is remarkable in that it is more orderly than other positions.  This will help maintain the clarity of the cornea compared to other alternative materials currently in use that are somewhat opaque.  It derives entirely from all-natural substances- The stem cells used are those that have been harvested from the cornea of the dog being treated or collected from recently deceased corpses so there is little chance of post-transplantation inflammation or irritation.  The structure for cells to adhere to is made from silk fibroin mixed with gelatin.   As time passes, stem cells create their own network of cells that form three-dimensional pieces even though the structural materials are naturally degraded by enzymes. They can be trimmed during the transplantation process – since the parts are three-dimensional sheets they can be trimmed to fit the wound where the cornea is missing.    Wounds heal faster – stem cells are living cells and have properties that help in network formation causing cell adhesion.  They also help with strengthening and building collagen so that wound healing can occur.  This is different from using graft sheets that do not contain living cells.    

At present, the “3D artificial cornea from stem cells” innovation is still in the laboratory testing stage to study whether the 3D artificial cornea can actually be used as a cornea replacement, and to determine how it interacts with the animal’s body.  According to Veterinary Professor Dr. Chutirat in many countries research on such innovations is also currently underway at the laboratory level. 

“The research we have done has produced satisfactory results.  It is expected that this innovation will be applied to dogs in the next few years.  Moreover, we have plans to apply this knowledge to cats as well from cell collection, locating cells, separating cells, and arranging cells” Dr. Chutirat concluded.   

Those who are interested can further read the research paper on the subject at https://pubmed.ncbi.nlm.nih.gov/35120168/ 

For the full release and more images, please visit: https://www.chula.ac.th/en/highlight/170754/

About Chulalongkorn University

Chulalongkorn University has made the world’s top 50 university list for employment outcomes, which reflects both the high employment rate and workability of Chula graduates. The university is also listed as the best in Thailand for the 15th Consecutive Year (since 2009), according to the newly released QS World University Rankings 2024, putting Chula at 211th in the world, up from 244th last year.

Social Media:
Facebook: https://www.facebook.com/ChulalongkornUniversity
Youtube: https://www.youtube.com/chulauniversity
Linkedin: https://www.linkedin.com/school/15101896/

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/3d-artificial-cornea-from-stem-cells-chula-researchers-advance-canine-corneal-wound-treatment-302191982.html

SOURCE Chulalongkorn University

Continue Reading

Technology

Elementix and Lightning Docs Announce Reporting Partnership to Deliver Industry-Comprehensive Data on Business-Purpose Lending

Published

on

By

Each company’s monthly report will draw on shared recorded transaction data and loan-level document data, giving lenders, brokers, and investors a more complete view of current bridge, fix-and-flip, construction, and DSCR lending.

IRVINE, Calif., Oct. 27, 2026 /PRNewswire/ — Elementix, a leading provider of aggregated data on business-purpose lending, and Lightning Docs, the premier loan document automation platform for private lenders, Non-QM lenders, credit unions, and law firms, today announced a data-sharing partnership to strengthen reporting on the business-purpose lending market.

The partnership brings together two complementary datasets. Elementix aggregates recorded real estate transactions nationwide, including mortgages, deeds, satisfactions, assignments, and preforeclosure filings, providing a comprehensive picture of lender activity, loan volume, and market share. Lightning Docs captures loan-level terms at the point of document generation, including interest rates, loan amounts, and loan structures, from a document automation platform used by 60% of the nation’s top 50 private lenders. Combined, the two sources produce a level of coverage and detail that has been unprecedented in the private lending space.

“Private lending has long been an opaque industry, with limited data on interest rates, loan amounts, geographic trends, and other metrics that are vital to running a profitable operation,” said Nema Daghbandan, CEO of Lightning Docs. “Lightning Docs set the standard for monthly private lending market reporting, and this partnership raises it. By pairing our loan-level data with Elementix’s transaction data, we are delivering reporting with the scale, precision, and depth the market has been missing, and providing lenders, brokers, and investors a clearer view of the industry than they have ever had before.”

Each report, delivered at a regular monthly cadence, will cover bridge, fix-and-flip, ground-up construction, and DSCR loans, with aggregated data on interest rates, loan amounts, loan volume, lender activity, geographic trends at the state and regional level. All data will be aggregated and anonymized, with no borrower- or lender-specific loan terms disclosed.

“Managing risk in private lending starts with understanding the borrower and the broader market, yet lenders often have to make decisions with incomplete information. Elementix was built to help lenders understand that risk through public record data, and partnering with Lightning Docs adds the loan-level detail that completes the picture. Together, we’re helping lenders better understand market conditions and bring that context into how they assess and manage risk,” said Cameron Kelliher, founder and CEO of Elementix.

The first joint report is scheduled for release in November 2026. Reports will be published on the Lightning Docs and Elementix websites and distributed to subscribers of both companies.

About Elementix
Elementix is the borrower intelligence platform for private lenders. It helps lenders identify active investors, verify experience for better credit decisions, and reach decision-makers with leading contact data accuracy. For more information, visit www.elementix.com.

About Lightning Docs
Initially developed by nationally recognized private lending attorneys, Lightning Docs is the industry’s leading automated loan document software for lenders who make business-purpose loans. The platform instantly produces attorney-grade, compliant loan documents across all 50 states. It covers every business-purpose loan type, including short-term bridge and fix-and-flip loans, 30-year DSCR rental loans, ground-up construction, and complex modifications. Lightning Docs is the official loan document software of the American Association of Private Lenders®. More than 60% of the nation’s top 50 private lenders use it, along with many of the country’s largest Non-QM lenders. Since 2018, lenders have originated more than $100 billion using Lightning Docs. For more information, visit www.lightningdocs.ai.

View original content to download multimedia:https://www.prnewswire.com/news-releases/elementix-and-lightning-docs-announce-reporting-partnership-to-deliver-industry-comprehensive-data-on-business-purpose-lending-302921069.html

SOURCE Lightning Docs LLC

Continue Reading

Technology

Therap Services Enhances Therap Connect with Personalized Sleep Insights for Human Services Providers

Published

on

By

TORRINGTON, Conn., Oct. 27, 2026 /PRNewswire/ — Therap Services, the national leader in HIPAA-compliant electronic documentation solutions for Intellectual and Developmental Disabilities (IDD), Home and Community-Based Services (HCBS), and Long-Term Services and Supports (LTSS) industries, has introduced advanced Personalized Sleep Insights to its Therap Connect platform. This enhancement integrates ambient room monitoring with sleep tracking data to help care teams understand and optimize environmental factors affecting the sleep quality of individuals.

Understanding Environmental Factors for Better Rest

Tracking overnight sleep patterns is vital for maintaining physical health, emotional well-being, and individual safety. The updated Therap Connect module introduces a ‘Personalized Sleep Insights’ feature that evaluates three months of historical data from Withings sleep monitors and Watchdog room sensors. By evaluating sleep start times alongside ambient room temperature and humidity, the system highlights optimal environmental conditions to support healthier sleep habits and proactive care planning.

Streamlined Platform Workflows and Daily Tracking

Designed for ease of use, this update helps teams manage daily monitoring more efficiently. Staff can quickly review overnight alerts directly on dashboard views, manage notification settings in one place, and conveniently copy form details with a single click. These practical updates save time on routine administrative tasks, allowing care managers and staff to focus on monitoring health parameters.

Frequently Asked Questions (FAQs)

Does Therap Connect offer sleep tracking capabilities? 

Yes. Therap Services provides integrated sleep and health tracking through Therap Connect, combining continuous sensor data with daily documentation tools.

How do Personalized Sleep Insights in Therap Services help human services providers?

It analyzes sleep schedules, room temperature, and humidity data to identify optimal sleep environments, helping care teams make data-informed adjustments to support health outcomes.

Does Therap Connect require extra software for sleep tracking? 

No. Therap Connect operates through its own dedicated, secure web-based portal, allowing teams to access environmental and sleep tracking insights natively without installing third-party software.

For more information about Therap Connect, please visit: https://www.therapconnect.net/

About Therap Services

Therap Services provides HIPAA-compliant software for documentation, communication, reporting, EVV, and billing.

Learn more: https://www.therapservices.net/

View original content:https://www.prnewswire.com/news-releases/therap-services-enhances-therap-connect-with-personalized-sleep-insights-for-human-services-providers-302921017.html

SOURCE Therap Services

Continue Reading

Technology

Meet Providi: One Company Behind Cerbo and OptiMantra

Published

on

By

The new name reflects a long-term commitment to the cash-pay personalized care market, where Cerbo and OptiMantra keep their brands and together serve nearly 7,000 clinics.

ATLANTA, Oct. 27, 2026 /PRNewswire/ — Providi launched today as the corporate brand of the company behind Cerbo and OptiMantra, two long-standing products in the cash-pay personalized care market. The companies combined in 2025, backed by a growth investment from Mainsail Partners. Cerbo and OptiMantra will continue as product brands within Providi.

Together, the two providers of electronic health record (EHR) and practice management products support nearly 7,000 clinics. These include functional, integrative, longevity, wellness, direct primary care, concierge, med spa and behavioral health practices. Both have served the market since 2011.

The name Providi combines “provi,” for the provider at the center of every practice, with “vidi,” Latin for “I saw.” It stands for a company that starts with the provider and can see where personalized care is going.

Providi’s mission is to empower personalized care providers to deliver better patient outcomes and create thriving practices. That mission is already shaping the product roadmap. With the Cerbo and OptiMantra teams building together, new capabilities reach providers faster, and AI Scribe is the first example. Available now, Cerbo AI Scribe captures visit notes automatically, so providers spend less time charting between visits or after hours. OptiMantra AI Scribe, built on lessons from the Cerbo launch, is coming to OptiMantra providers soon.

“Personalized care providers built this market one practice at a time, each one designed around the time, attention and care they believe every patient deserves,” said Jeff Hindman, CEO of Providi. “Cerbo and OptiMantra have each earned the trust of thousands of practices, and Providi exists to amplify that work. Coming together as one company accelerates the innovation we can bring to market and enables us to invest more in both products. Our focus remains giving the providers already running our products and the new providers entering the market the technology they need to succeed.”

Providers can expect to log in to the same Cerbo and OptiMantra products, reach out to the same reps and receive support, onboarding and product updates the same way they do today. They will start to see the Providi name at combined events and in company communications, and they’ll feel it in their products: two teams sharing what they learn, active investment in both products and new capabilities reaching their practices sooner.

About Providi

Providi is the company behind Cerbo and OptiMantra, two electronic health record (EHR) and practice management products serving the cash-pay personalized care market. Together, Cerbo and OptiMantra support nearly 7,000 clinics in functional, integrative, longevity, wellness, direct primary care, concierge, med spa and behavioral health. Providi is committed to meeting the specialty workflow needs of these practices and continues to invest in both products to help providers achieve better patient outcomes, grow their practices and operate more efficiently. For more information, visit providico.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/meet-providi-one-company-behind-cerbo-and-optimantra-302921038.html

SOURCE Providi

Continue Reading

Trending